Exelixis Inc Cost of Goods Sold (Deprecated 2018-01-31)
Exelixis Inc (EXEL) reported Cost of Goods Sold (Deprecated 2018-01-31) of $6.00 million for the 3-month period ending 2018-06-29, per its 10-Q filed 2018-08-01.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-08-01
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-29 was $6.00M, a 98.97% increase year-over-year.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-30 was $5.64M, a 76.05% increase year-over-year.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $4.66M, a 89.74% increase year-over-year.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $3.01M, a 93.21% increase year-over-year.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $15.07M, a 129.95% increase from fiscal 2016.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $6.55M.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $6.55M, a 68.22% increase from fiscal 2016.
- Exelixis Inc cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $3.90M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-29 | $6.00M 10-Q · filed 2018-08-01 | $11.64M 10-Q · filed 2018-08-01 | ||
| 2018-03-30 | $5.64M 10-Q · filed 2018-05-02 | |||
| 2017-12-29 | $15.07M 10-K · filed 2018-02-26 | |||
| 2017-09-30 | $4.66M 10-Q · filed 2017-11-01 | $7.67M derived: sum of 2 quarters · filed 2018-08-01 | $10.88M 10-Q · filed 2017-11-01 | $12.73M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-06-30 | $3.01M 10-Q · filed 2018-08-01 | $6.22M 10-Q · filed 2017-08-02 | $8.07M derived: sum of 3 quarters · filed 2018-08-01 | $10.52M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $3.20M 10-Q · filed 2017-05-01 | $5.05M derived: sum of 2 quarters · filed 2018-05-02 | $7.51M derived: sum of 3 quarters · filed 2018-05-02 | $9.07M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $4.31M derived: sum of 2 quarters · filed 2017-11-01 | $5.87M derived: sum of 3 quarters · filed 2017-11-01 | $6.55M 10-K · filed 2017-02-27 |
| 2016-12-30 | $6.55M 10-K · filed 2018-02-26 | |||
| 2016-09-30 | $2.46M 10-Q · filed 2017-11-01 | $4.01M derived: sum of 2 quarters · filed 2017-11-01 | $4.70M 10-Q · filed 2017-11-01 | $5.72M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | $1.56M 10-Q · filed 2017-08-02 | $2.25M 10-Q · filed 2017-08-02 | $3.27M derived: sum of 3 quarters · filed 2017-08-02 | $4.69M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | $685.00K 10-Q · filed 2017-05-01 | $1.71M derived: sum of 2 quarters · filed 2017-05-01 | $3.13M derived: sum of 3 quarters · filed 2017-05-01 | $3.81M derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-01-01 | $3.90M 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.44M derived: sum of 2 quarters · filed 2017-02-27 | $3.13M derived: sum of 3 quarters · filed 2017-02-27 | $3.90M 10-K · filed 2017-02-27 |
| 2015-09-30 | $1.42M 10-Q · filed 2016-11-03 | $2.11M derived: sum of 2 quarters · filed 2016-11-03 | $2.87M 10-Q · filed 2016-11-03 | $3.56M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $686.00K 10-Q · filed 2016-08-03 | $1.45M 10-Q · filed 2016-08-03 | $2.14M derived: sum of 3 quarters · filed 2017-02-27 | $2.71M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $766.00K 10-Q · filed 2016-05-04 | $1.45M derived: sum of 2 quarters · filed 2017-02-27 | $2.02M derived: sum of 3 quarters · filed 2017-02-27 | $2.50M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.26M derived: sum of 2 quarters · filed 2017-02-27 | $1.73M derived: sum of 3 quarters · filed 2017-02-27 | $2.04M 10-K · filed 2017-02-27 |
| 2014-09-30 | $573.00K 10-Q · filed 2015-11-10 | $1.05M derived: sum of 2 quarters · filed 2015-11-10 | $1.36M 10-Q · filed 2015-11-10 | $1.62M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $477.00K 10-Q · filed 2015-08-11 | $786.00K 10-Q · filed 2015-08-11 | $1.05M derived: sum of 3 quarters · filed 2016-02-29 | $1.34M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $309.00K 10-Q · filed 2015-04-30 | $572.00K derived: sum of 2 quarters · filed 2016-02-29 | $862.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.15M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $553.00K derived: sum of 2 quarters · filed 2016-02-29 | $838.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.12M 10-K · filed 2016-02-29 |
| 2013-09-30 | $290.00K 10-Q · filed 2014-11-04 | $575.00K derived: sum of 2 quarters · filed 2014-11-04 | $855.00K 10-Q · filed 2014-11-04 | $855.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $285.00K 10-Q · filed 2014-07-31 | $565.00K 10-Q · filed 2014-07-31 | $565.00K derived: sum of 3 quarters · filed 2015-03-02 | $565.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $280.00K 10-Q · filed 2014-05-01 | $280.00K derived: sum of 2 quarters · filed 2015-03-02 | $280.00K derived: sum of 3 quarters · filed 2015-03-02 | $280.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 |
| 2012-09-30 | $0.00 10-Q · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |